Michael Scolaro

Michael Scolaro

Oct 16, 2017

Group 6 Copy 162
1
Please wait...

About This Project

We hypothesize that targeted delivery of Curcumin to antigen presenting cells in the immune system can suppress tumor growth for a variety of cancers. This study will examine tumor responses to Curcumin in a colon cancer mouse model when given alone or in combination with an FDA-approved immune Checkpoint Inhibitor. Positive results will lead to Fast-Track FDA applications for human and companion pet animal cancer trials.

Blast off!

Browse Other Projects on Experiment

Related Projects

Managing Congenital Adrenal Hyperplasia in the Amish Population

Congenital adrenal hyperplasia (CAH) is a disorder that affects the production of hormones critical for...

How does taking Ritalin affect depersonalization-derealization disorder patients?

We are investigating Ritalin's role in alleviating symptoms of depersonalization-derealization (DPDR) disorder...

MyHealthEd

Each child deserves quality comprehensive sexual health education. No child is the same, so why...

Backer Badge Funded